Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
Novo Nordisk lowers sales and operating profit outlook for 2025
07:02am, Tuesday, 29'th Jul 2025
Bagsværd, Denmark, 29 July 2025 – Novo Nordisk today announced sales and operating profit growth at constant exchange rates (CER) for the first six months of 2025 and updated full-year sales and o
Highlights – June Quarter 2025
04:15pm, Monday, 28'th Jul 2025
PERTH, Australia, July 28, 2025 (GLOBE NEWSWIRE) -- Novo Resources Corp. (Novo or the Company) (ASX: NVO) (TSX: NVO) (OTCQB: NSRPF) is pleased to report on the key activities carried out by the Compan
3 Surprisingly Underrated Stocks to Buy Right Now
06:42am, Monday, 28'th Jul 2025
You'd think that companies with long, successful track records and market caps in the hundreds of billions of dollars would be viewed as relatively formidable. However, that's not always the case.
Novo Nordisk faces 'show me' moment to boost Wegovy growth after US copycat ban
06:04am, Monday, 28'th Jul 2025
A U.S. ban on copycat versions of Novo Nordisk's Wegovy has begun to lift use of the weight loss drug, but the company will need to show more robust growth in the months ahead to bolster market confid
2 Healthcare Stocks That Are Losing to the S&P 500 This Year
09:15am, Sunday, 27'th Jul 2025
Even with all the volatility and the flirting with bear-market territory, the S&P 500 index is well in the green this year, up about 8% since early January. Some stocks haven't been so lucky, though.
3 'Wide Moat' SWANs
11:33am, Friday, 25'th Jul 2025
Despite a greedy market, we've found three quality stocks - NVO, RGA, and CP - offering strong value, growth, and reliable dividends. Novo Nordisk leads obesity treatment with strong GLP-1 drugs, a ro
Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Friday, 25'th Jul 2025
Recently, Zacks.com users have been paying close attention to Novo Nordisk (NVO). This makes it worthwhile to examine what the stock has in store.
Bagsværd, Denmark, 25 July 2025 – Novo Nordisk today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommendin
Novo Nordisk (NVO) is a Top-Ranked Momentum Stock: Should You Buy?
10:50am, Thursday, 24'th Jul 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Novo Nordisk: Undervalued Despite Strong Growth Trend & Solid Market Share
09:24am, Thursday, 24'th Jul 2025
I am bullish on Novo Nordisk due to its 62% global GLP-1 market share and dominant Ozempic sales, supporting long-term leadership. Novo Nordisk's diversified GLP-1 portfolio, including Rybelsus and pe
This Weight-Loss Stock Sank After Earnings. It's Still a Risk for Eli Lilly, Novo Nordisk.
08:48am, Thursday, 24'th Jul 2025
Viking Therapeutics is expected to disclose data on its oral weight-loss drug VK2735.
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (July 2025)
08:04pm, Wednesday, 23'rd Jul 2025
Shares of Pfizer (NYSE: PFE) surged 8.24% over the past month, reducing the stock’s year-to-date loss to 5.02%. Over the past year, PFE has fallen by 8.75%. Recently, the FDA announced it will o
Amgen vs. Novo Nordisk: Which Pharma Giant Is the Better Buy?
10:51am, Wednesday, 23'rd Jul 2025
AMGN's deep pipeline and rare disease expansion may outweigh NVO's GLP-1 dominance and leadership shakeup.
Here's Why Novo Nordisk (NVO) is a Strong Value Stock
10:41am, Wednesday, 23'rd Jul 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Novo Nordisk: The Market Hasn't Given It Enough Respect
09:22am, Wednesday, 23'rd Jul 2025
Healthcare stocks have lagged the S&P 500, with Novo Nordisk already hit hard by intense competition from Eli Lilly. Despite recent setbacks and a decelerating growth outlook, Novo Nordisk's valuation
